PharmaTox
The PharmaTox Strategic Research Initiative aims to generate novel insight on effects of pharmaceuticals on human neurotoxicity and neurodevelopment.
PharmaTox was established January 1st 2015 as a prioritized research initiative supported by the Faculty of Mathematics and Natural Sciences.
The research projects within PharmaTox involve specialists in neurotoxicology, pharmacology, teratology, statistics, bioinformatics, epigenetics and epidemiology.
News
-
New article on the use and validity of child neurodevelopment outcome measures
July 12, 2019 7:24 PM
See a video abstract of the recently published systematic review on the use and validity of child neurodevelopent outcome measures in studies on prenatal exposure to psychotropic and analgesic medications.
-
New article on prenatal exposure to benzodiazepines and z-hypnotics
July 4, 2019 3:35 PM
New article by PharmaSafe researchers on the impact of prenatal exposure to benzodiazepines and z-hypnotics on behavioral problems at 5 years of age.
-
European mega-venture for safe medications during pregnancy
June 11, 2019 2:34 PM
Professor Hedvig Nordeng is one of the researchers involved in the new and massive European research project ConcePTION, where the aim is to generate the knowledge that pregnant women want – and need – about the safety of medications.
-
2nd Neurogenesis Conference in Nassau, Bahamas, 2019
June 11, 2019 2:21 PM
Read the travel report from PhD students Nils A. Labba and Martin Falck.
-
PharmaTox at the NFIF conference 2019
June 11, 2019 2:08 PM
PharmaTox PhD students had several contributions to NFIF's annual conference.
